Working in a way that goes beyond the traditional CRO
At ICON our reputation is built on enduring partnerships that are driven to advance medicine and make a difference in the world. Since our inception in 1990, we’ve partnered with pharmaceutical, biotech, and medical device clients, collaborating, innovating, and finding new ways together to improve outcomes. This is the lifeblood of our business and the vision that has shaped our strategy more than any other.
The COVID-19 pandemic has taught us that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together, in a truly collaborative way. The opportunity now is to take what we have learned and continue to drive progress. At ICON, this means working in a way that goes beyond a traditional CRO. It means being your trusted partner.
As the world’s leading clinical research organisation powered by healthcare intelligence, and the largest global provider of functional service provision (FSP), ICON can transform organisational flexibility and operational efficiency. Our operational, functional and therapeutic specialists offer a range of full -service and FSP models that can be customised to deliver the most efficient operating model to meet your needs. We bring a suite of capabilities, expertise and technology to augment your operations, increase R&D efficiencies and improve site engagement to access patient populations and deliver timelines and milestones.
We understand that first and foremost, clients want consistent and effective clinical development. Critical to that is better quality data and the insights which that data delivers.
We are focused on new and better ways of designing and executing clinical research and anticipating future trends to move beyond the status quo. We apply our healthcare intelligence, the harmonisation of our human experience and expertise, with the most robust suite of clinical capabilities in the industry, technology, and insightful data resources. We are focused on the factors that are most critical to sponsors and that drive value. Our overarching goal is simple; rapid access to, and analysis of, high-quality data to speed up and improve decision-making.
We share the commitment to achieve your clinical development goals. Historically, CRO/sponsor partnerships were one-directional. There is now recognition that to evolve clinical research, partnerships must be mutually beneficial. ICON delivers well established partnership models, and governance structures, supported by robust tools and technologies to ensure open, transparent communications.
Our values of integrity, collaboration, agility and inclusion drive our clients’ success. At its core, ICON’s mission is to improve health and lives. We are also committed to contributing to the 2030 United Nations sustainable development goals and are proud that our work contributes to their advancement. Our ICON Cares initiative incorporates our ESG pillars, which include diversity, inclusion and belonging as well as our corporate philanthropic initiatives.
This is an exciting time for our industry. By partnering together, ICON and our clients are driving progress in:
We have set our ambition to be over 20% better than industry benchmarks for our client milestones and outcomes. We track ourselves against these benchmarks and are transparent in sharing our performance.